Influence of Cocaine History on the Behavioral Effects of Dopamine D3 Receptor-Selective Compounds in Monkeys

被引:0
|
作者
B L Blaylock
R W Gould
A Banala
P Grundt
R R Luedtke
A H Newman
M A Nader
机构
[1] Wake Forest University School of Medicine,Department of Physiology and Pharmacology
[2] Medicinal Chemistry Section,Department of Pharmacology and Neuroscience
[3] National Institutes on Drug Abuse,undefined
[4] Intramural Research Program,undefined
[5] National Institutes of Health,undefined
[6] University of North Texas Health Science Center,undefined
来源
Neuropsychopharmacology | 2011年 / 36卷
关键词
addiction and substance abuse; cocaine; dopamine D; receptors; self-administration; reinstatement; nonhuman primates;
D O I
暂无
中图分类号
学科分类号
摘要
Although dopamine D3 receptors have been associated with cocaine abuse, little is known about the consequences of chronic cocaine on functional activity of D3 receptor-preferring compounds. This study examined the behavioral effects of D3 receptor-selective 4-phenylpiperazines with differing in vitro functional profiles in adult male rhesus monkeys with a history of cocaine self-administration and controls. In vitro assays found that PG 619 (N-(3-hydroxy-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide HCl) was a potent D3 antagonist in the mitogenesis assay, but a fully efficacious agonist in the adenylyl cyclase assay, NGB 2904 (N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide HCl) was a selective D3 antagonist, whereas CJB 090 (N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide HCl) exhibited a partial agonist profile in both in vitro assays. In behavioral studies, the D3 preferential agonist quinpirole (0.03–1.0 mg/kg, i.v.) dose-dependently elicited yawns in both groups of monkeys. PG 619 and CJB 090 elicited yawns only in monkeys with an extensive history of cocaine, whereas NGB 2904 did not elicit yawns, but did antagonize quinpirole and PG 619-elicited yawning in cocaine-history monkeys. In another experiment, doses of PG 619 that elicited yawns did not alter response rates in monkeys self-administering cocaine (0.03–0.3 mg/kg per injection). Following saline extinction, cocaine (0.1 mg/kg) and quinpirole (0.1 mg/kg), but not PG 619 (0.1 mg/kg), reinstated cocaine-seeking behavior. When given before a cocaine prime, PG 619 decreased cocaine-elicited reinstatement. These findings suggest that (1) an incongruence between in vitro and in vivo assays, and (2) a history of cocaine self-administration can affect in vivo efficacy of D3 receptor-preferring compounds PG 619 and CJB 090, which appear to be dependent on the behavioral assay.
引用
收藏
页码:1104 / 1113
页数:9
相关论文
共 50 条
  • [1] Influence of Cocaine History on the Behavioral Effects of Dopamine D3 Receptor-Selective Compounds in Monkeys
    Blaylock, B. L.
    Gould, R. W.
    Banala, A.
    Grundt, P.
    Luedtke, R. R.
    Newman, A. H.
    Nader, M. A.
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (05) : 1104 - 1113
  • [2] Erratum: Influence of Cocaine History on the Behavioral Effects of Dopamine D3 Receptor-Selective Compounds in Monkeys
    B L Blaylock
    R W Gould
    A Banala
    P Grundt
    R R Luedtke
    A H Newman
    M A Nader
    Neuropsychopharmacology, 2012, 37 : 2550 - 2550
  • [3] Influence of Cocaine History on the Behavioral Effects of Dopamine D3 Receptor-Selective Compounds in Monkeys (vol 36, pg 1104, 2011)
    Blaylock, B. L.
    Gould, R. W.
    Banala, A.
    Grundt, P.
    Luedtke, R. R.
    Newman, A. H.
    Nader, M. A.
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (11) : 2550 - 2550
  • [4] Characterization of Dopamine D3 receptor-selective compounds on unconditioned behaviors and food/drug choice in cocaine and methamphetamine self-administering rhesus monkeys
    Nader, Susan H.
    Blaylock, B. L.
    Wilson, W. D.
    Banala, A.
    Newman, A. H.
    Nader, M. A.
    FASEB JOURNAL, 2012, 26
  • [5] Effects of selective dopamine D3 receptor compounds in nonhuman primate models of cocaine and methamphetamine abuse
    John, William
    Green, Heather
    Newman, Amy
    Nader, Michael
    FASEB JOURNAL, 2014, 28 (01):
  • [6] In vivo Behavioral Characterization of ML417, a Novel D3 Dopamine Receptor-selective Agonist
    Akano, Emmanuel Oladele
    Moritz, Amy Elizabeth
    Preston, Michael Wayne
    Lobb, Collin Jethro
    Du Hoffmann, Johann Faustus
    Free, R. Benjamin
    Frankowski, Kevin J.
    Walters, Judith R.
    Sibley, David R.
    FASEB JOURNAL, 2018, 32 (01):
  • [7] Identification of a Novel, Highly Potent D3 Dopamine Receptor-selective Agonist
    Sibley, David
    Moritz, Amy
    Free, R. Benjamin
    Conroy, Jennie
    Weiner, Warren
    Barnaeva, Elena
    Southall, Noel
    Ferrer, Marc
    Javitch, Jonathan
    Aube, Jeffrey
    Frankowski, Kevin
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S287 - S288
  • [8] Synthesis & evaluation of a dopamine D3 receptor-selective positron emission tomography probe
    Stewart, Megan
    Hockley, Brian
    Scott, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [9] Dopamine D3 and D2 Receptor Mechanisms in the Abuse-Related Behavioral Effects of Cocaine: Studies with Preferential Antagonists in Squirrel Monkeys
    Achat-Mendes, Cindy
    Grundt, Peter
    Cao, Jianjing
    Platt, Donna M.
    Newman, Amy Hauck
    Spealman, Roger D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (02): : 556 - 565
  • [10] Novel selective dopamine D3 receptor modulators for the treatment of cocaine addiction
    Chen, Peng-Jen
    Blass, Benjamin
    Gordon, John
    Luedtke, Robert
    Taylor, Michelle
    Korzekwa, Kenneth
    Ye, Min
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254